Holdings in GSK
| Report Date |
Value (USD) |
Shares |
Change |
Type |
Discretion |
Filed |
| 2025-12-31 |
$39,609,411 |
807,696 |
+220.5%
|
Shares |
Defined |
2026-02-12 |
| 2025-12-31 |
$12,358,080 |
252,000 |
+193.4%
|
Shares |
Defined |
2026-02-12 |
| 2025-12-31 |
$4,212,536 |
85,900 |
-94.7%
|
Shares |
Defined |
2026-02-12 |
| 2025-09-30 |
$70,304,315 |
1,628,923 |
+443.0%
|
Shares |
Defined |
2025-11-14 |
| 2025-09-30 |
$12,948,000 |
300,000 |
+113.4%
|
Shares |
Defined |
2025-11-14 |
| 2025-09-30 |
$6,068,296 |
140,600 |
-92.5%
|
Shares |
Defined |
2025-11-14 |
| 2025-06-30 |
$71,767,640 |
1,868,949 |
+542.9%
|
Shares |
Defined |
2025-08-14 |
| 2025-06-30 |
$11,162,880 |
290,700 |
+264.3%
|
Shares |
Defined |
2025-08-14 |
| 2025-06-30 |
$3,064,320 |
79,800 |
+353.4%
|
Shares |
Defined |
2025-08-14 |
| 2025-03-31 |
$681,824 |
17,600 |
-73.4%
|
Shares |
Defined |
2025-05-19 |
| 2025-03-31 |
$2,560,714 |
66,100 |
-95.7%
|
Shares |
Defined |
2025-05-19 |
| 2025-03-31 |
$59,606,525 |
1,538,630 |
+44.8%
|
Shares |
Defined |
2025-05-19 |
| 2024-12-31 |
$35,944,131 |
1,062,807 |
+2210.5%
|
Shares |
Defined |
2025-02-14 |
| 2024-12-31 |
$1,555,720 |
46,000 |
+360.0%
|
Shares |
Defined |
2025-02-14 |
| 2024-09-30 |
$408,800 |
10,000 |
-96.0%
|
Shares |
Defined |
2024-11-15 |
| 2024-09-30 |
$10,321,054 |
252,472 |
-47.2%
|
Shares |
Defined |
2024-11-15 |
| 2024-06-30 |
$18,420,902 |
478,465 |
+271.9%
|
Shares |
Defined |
2024-08-15 |
| 2024-03-31 |
$5,514,667 |
128,637 |
-71.6%
|
Shares |
Defined |
2024-05-16 |
| 2023-12-31 |
$16,785,844 |
452,937 |
+451.8%
|
Shares |
Defined |
2024-02-15 |
| 2023-09-30 |
$2,975,545 |
82,084 |
+46.5%
|
Shares |
Defined |
2023-11-15 |
| 2023-06-30 |
$1,996,731 |
56,025 |
-58.2%
|
Shares |
Defined |
2023-08-14 |
| 2023-03-31 |
$4,771,881 |
134,117 |
-92.7%
|
Shares |
Defined |
2023-05-16 |
| 2022-12-31 |
$64,168,345 |
1,826,077 |
+1269.6%
|
Shares |
Defined |
2023-02-15 |
| 2022-09-30 |
$3,923,812 |
133,327 |
—
|
Shares |
Defined |
2022-11-15 |
